Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) Short Interest Update

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) saw a large decrease in short interest in the month of July. As of July 31st, there was short interest totaling 2,344 shares, a decrease of 46.7% from the July 15th total of 4,398 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average trading volume of 27,653 shares, the short-interest ratio is presently 0.1 days.

Aimei Health Technology Stock Up 0.4%

Shares of Aimei Health Technology stock opened at $12.05 on Friday. The firm has a market cap of $38.20 million, a price-to-earnings ratio of 200.87 and a beta of 0.90. The business has a fifty day simple moving average of $20.80 and a 200-day simple moving average of $32.80. Aimei Health Technology has a fifty-two week low of $6.75 and a fifty-two week high of $130.37.

Aimei Health Technology (NASDAQ:AFJK) last announced its earnings results on Thursday, August 13th. The company reported ($0.03) earnings per share for the quarter.

Hedge Funds Weigh In On Aimei Health Technology

Large investors have recently made changes to their positions in the business. Jane Street Group LLC bought a new stake in shares of Aimei Health Technology in the 4th quarter worth approximately $302,000. Geode Capital Management LLC bought a new stake in Aimei Health Technology during the fourth quarter worth approximately $413,000. Quarry LP boosted its holdings in Aimei Health Technology by 6.4% during the third quarter. Quarry LP now owns 167,081 shares of the company’s stock worth $1,891,000 after buying an additional 10,000 shares in the last quarter. Finally, Clear Street Group Inc. boosted its holdings in Aimei Health Technology by 36.5% during the fourth quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock worth $5,334,000 after buying an additional 22,294 shares in the last quarter. Institutional investors own 45.58% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of Aimei Health Technology in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Aimei Health Technology presently has a consensus rating of “Sell”.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.